Powered by

Hydroxychloroquine study shuts down at Henry Ford; Not enough participants to analyze drug's effectiveness

Jan 13, 2021 - Detroit Free Press

Promoted in April as the first large-scale drug study on the effectiveness of hydroxychloroquine to protect against COVID-19, the Detroit-based clinical trial has quietly been iced.

Henry Ford Health System officials told Bridge Michigan they could not find enough participants to continue studying whether the drug could help beat back the deadly pandemic.

Hydroxychloroquine - an antimalarial drug that has also proven useful in treating rheumatoid arthritis, lupus and other inflammato...